METTL1, as one of the key tRNA-modifying enzymes, has been extensively reported to promote cancer development by mediating tRNA m7G modifications in lung cancer, ICC, HCC, and bladder cancer (16–20). This evidence concerns the gene METTL1 and urinary bladder cancer.